Pluristem Therapeutics PLX Cells Found to Be Effective in Treating Neuropathic and Inflammatory Pain
8/9/2010 8:25:45 AM
HAIFA, Israel--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (Nasdaq: PSTI) (DAX: PJT) today announced the results of two separate pre-clinical studies in animal models which demonstrated that its PLacental eXpanded (PLX) cell therapy may be an effective treatment for both neuropathic and inflammatory nerve pain. These animal studies were conducted in collaboration with the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and the Department of Anesthesiology and Operative Intensive Care Medicine, both at the Charité-Universitätsmedizin of Berlin, Germany.
comments powered by